Hello guest, Register  |  Sign In
Virologica Sinica, 21 (4) : 348-352, 2006
Research Article
Inhibition of Hepatitis B Virus Replication in vitro and in vivo by RNAi
1. Division of Clinical Immunology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2. Taihe Hospital of Yunyang Medical Collage, Shiyan 442000, China
In this study, psiHBs was constructed through the backbone of psiRNA-vector to transcribe a small hairpin RNA(shRNA) corresponding to the messenger RNA of the HBV small surface antigen. After transfection of HepG2 cells or Balb/c mice with psiHBs and pHBV1.3, a plasmid containing 1.3-genomic-length replicative-competent HBV DNA, the viral antigens were evaluated by ELISA, Western blotting, or immunohistochemistry and the viral replicative intermediates were detected by Southern hybridization. The data indicated that after transfection of HepG2 cells with pHBV1.3 and psiHBs, the HBsAg and HBeAg levels were reduced by over 90%, and the replicative intermediates in cells were decreased to 10% relative to control. In hydrodynamic injection mouse model, Balb/c mice were co-injected with pHBV1.3 and psiHBs. The HBsAg levels in mice sera were reduced by 80% relative to the control group, whereas the number of HBcAg positive hepatocytes in the mouse liver sections was decreased substantially by 75.1%. Our study showed that shRNA inhibits the HBV replication and gene expression substantially and effectively. The RNAi-based approach might become a pentential and novel tool for medical therapeutics in the future.
  Published online: 20 Jul 2006
Home |  Resources |  About Us |  Support |  Contact Us |  Privacy |  Powered by CanSpeed | 
Copyright © 2015 Virologica Sinica. All rights reserved